Literature DB >> 28685059

Downregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell line.

Shibiao Zhong1, Aiyan Zhou2, Fanghua Qi2, Zhen Li1, Zeyan Yu1, Yongchao Lu2, Xudong Liu3.   

Abstract

Forkhead Box M1 (FoxM1) is one of the most important oncogenes, and overexpression of FoxM1 has been reported in many cancers, including colon cancer. In the present study, the authors attempted to reveal the mechanism underlying its effects on proliferation through autophagy in the sw480 cell line. FoxM1 is knocked down through short hairpin (sh)RNA in the sw480 cell line. A series of experiments were conducted to examine it function on proliferation and LC3 and P62 were used to measure level of autophagy. Autophagy in the shFoxM1 cell was demonstrated as significantly inhibited compared with the negative control. Additional auto-fluex was also tested, downregulation of FoxM1 served the same role as BA1 in autophagy. Furthermore, downregulating FoxM1 inhibited cell proliferation in the sw480 cell line.

Entities:  

Keywords:  autophagy; colon cancer; proliferation; shFoxM1; sw480 cell line

Year:  2017        PMID: 28685059      PMCID: PMC5492723          DOI: 10.3892/br.2017.915

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  12 in total

1.  Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

Authors:  Julian J Lum; Daniel E Bauer; Mei Kong; Marian H Harris; Chi Li; Tullia Lindsten; Craig B Thompson
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

2.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 3.  FOXM1, a typical proliferation-associated transcription factor.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2007-12       Impact factor: 3.915

4.  Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.

Authors:  Tanya V Kalin; I-Ching Wang; Timothy J Ackerson; Michael L Major; Carol J Detrisac; Vladimir V Kalinichenko; Alexander Lyubimov; Robert H Costa
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

5.  Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.

Authors:  Bin Bao; Zhiwei Wang; Shadan Ali; Dejuan Kong; Sanjeev Banerjee; Aamir Ahmad; Yiwei Li; Asfar S Azmi; Lucio Miele; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

6.  Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor.

Authors:  Jinsheng Yu; Hrishikesh Deshmukh; Jacqueline E Payton; Christopher Dunham; Bernd W Scheithauer; Tarik Tihan; Richard A Prayson; Abhijit Guha; Julia A Bridge; Rosalie E Ferner; Guy M Lindberg; Rebecca J Gutmann; Ryan J Emnett; Lorena Salavaggione; David H Gutmann; Rakesh Nagarajan; Mark A Watson; Arie Perry
Journal:  Clin Cancer Res       Date:  2011-02-16       Impact factor: 12.531

7.  Pro-proliferative FoxM1 is a target of p53-mediated repression.

Authors:  A M Barsotti; C Prives
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

Review 8.  Autophagy in the pathogenesis of disease.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

9.  ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).

Authors:  Pramudita R Prasetyanti; Emily Capone; Daniela Barcaroli; Daniela D'Agostino; Silvia Volpe; Antonina Benfante; Sander van Hooff; Valentina Iacobelli; Cosmo Rossi; Stefano Iacobelli; Jan Paul Medema; Vincenzo De Laurenzi; Gianluca Sala
Journal:  Oncotarget       Date:  2015-07-10

10.  Hospital-based colorectal cancer survival trend of different tumor locations from 1960s to 2000s.

Authors:  Yu-Jing Fang; Xiao-Jun Wu; Qian Zhao; Li-Ren Li; Zhen-Hai Lu; Pei-Rong Ding; Rong-Xin Zhang; Ling-Heng Kong; Fu-Long Wang; Jun-Zhong Lin; Gong Chen; Zhi-Zhong Pan; De-Sen Wan
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more
  4 in total

1.  Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.

Authors:  Meng Yue; Shiquan Li; Guoqiang Yan; Chenyao Li; Zhenhua Kang
Journal:  Cell Cycle       Date:  2018-01-05       Impact factor: 4.534

2.  FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.

Authors:  Zuhal Hamurcu; Nesrin Delibaşı; Ufuk Nalbantoglu; Elif Funda Sener; Nursultan Nurdinov; Bayram Tascı; Serpil Taheri; Yusuf Özkul; Hamiyet Donmez-Altuntas; Halit Canatan; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

3.  Piperlongumine promotes death of retinoblastoma cancer cells.

Authors:  Nathalie Allaman-Pillet; Daniel F Schorderet
Journal:  Oncotarget       Date:  2021-04-27

Review 4.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.